Page 936 - Williams Hematology ( PDFDrive )

910 Part VI: The Erythrocyte Chapter 58: The Porphyrias 911

114. Goodwin RG, Kell WJ, Laidler P, et al: Photosensitivity and acute liver injury in mye- 150. Bonkovsky HL, Schned AR: Fatal liver failure in protoporphyria. Synergism between
loproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ethanol excess and the genetic defect. Gastroenterology 90(1):191, 1986.
ferrochelatase gene in hematopoietic cells. Blood 107(1):60, 2006. 151. Bloomer JR: Pathogenesis and therapy of liver disease in protoporphyria. Yale J Biol
115. Bottomley SS, Tanaka M, Everett MA: Diminished erythroid ferrochelatase activity in Med 52(1):39, 1979.
protoporphyria. J Lab Clin Med 86(1):126, 1975. 152. Kniffen JC: Protoporphyrin removal in intrahepatic porphyrastasis. Gastroenterology
116. Piomelli S, Lamola AA, Poh-Fitzpatrick MF, et al: Erythropoietic protoporphyria and 58:1027, 1970.
lead intoxication: The molecular basis for difference in cutaneous photosensitivity. I. 153. Gross U, Frank M, Doss MO: Hepatic complications of erythropoietic protoporphyria.
Different rates of disappearance of protoporphyrin from the erythrocytes, both in vivo Photodermatol Photoimmunol Photomed 14(2):52, 1998.
and in vitro. J Clin Invest 56(6):1519, 1975. 154. Bechtel MA, Bertolone SJ, Hodge SJ: Transfusion therapy in a patient with erythropoi-
117. Sandberg S, Brun A, Hovding G, et al: Effect of zinc on protoporphyrin induced pho- etic protoporphyria. Arch Dermatol 117(2):99, 1981.
tohaemolysis. Scand J Clin Lab Invest 40(2):185, 1980. 155. Van Wijk HJ, Van Hattum J, Delafaille HB, et al: Blood exchange and transfusion ther-
118. Spikes JD: Porphyrins and related compounds as photodynamic sensitizers. Ann N Y apy for acute cholestasis in protoporphyria. Dig Dis Sci 33:1621, 1988.
Acad Sci 244:496, 1975. 156. McGuire BM, Bonkovsky HL, Carithers RL Jr, et al: Liver transplantation for erythro-
119. Goldstein BD, Harber LC: Erythropoietic protoporphyria: Lipid peroxidation and red poietic protoporphyria liver disease. Liver Transpl 11(12):1590, 2005.
cell membrane damage associated with photohemolysis. J Clin Invest 51(4):892, 1972. 157. Todd DJ, Callender ME, Mayne EE, et al: Erythropoietic protoporphyria, transfusion
120. Lim HW, Poh-Fitzpatrick MB, Gigli I: Activation of the complement system in patients therapy and liver disease. Br J Dermatol 127:534, 1992.
with porphyrias after irradiation in vivo. J Clin Invest 74(6):1961, 1984. 158. Muley SA, Midani HA, Rank JM, et al: Neuropathy in erythropoietic protoporphyrias.
121. Ryan EA: Histochemistry of the skin in erythropoietic protoporphyria. Br J Dermatol Neurology 51(1):262, 1998.
78(10):501, 1966. 159. Nordmann Y: Erythropoietic protoporphyria and hepatic complications. J Hepatol
122. Poh-Fitzpatrick MB. The erythropoietic porphyrias. Dermatol Clin 4(2):291, 1986. 16(1-2):4, 1992.
123. Berenson MM, Kimura R, Samowitz W, et al: Protoporphyrin overload in unrestrained 160. Poh-Fitzpatrick MB, Wang X, Anderson KE, et al: Erythropoietic protoporphyria:
rats: Biochemical and histopathologic characterization of a new model of protopor- Altered phenotype after bone marrow transplantation for myelogenous leukemia in a
phyric hepatopathy. Int J Exp Pathol 73(5):665, 1992. patient heteroallelic for ferrochelatase gene mutations. J Am Acad Dermatol 46:861, 2002.
124. Bloomer JR: The liver in protoporphyria. Hepatology 8(2):402, 1988. 161. Fontanellas A, Mazurier F, Landry M, et al: Reversion of hepatobiliary alterations by
125. Bloomer JR, Enriquez R: Evidence that hepatic crystalline deposits in a patient with bone marrow transplantation in a murine model of erythropoietic protoporphyria.
protoporphyria are composed of protoporphyrin. Gastroenterology 82(3):569, 1982. Hepatology 32(1):73, 2000.
126. Bloomer J, Wang Y, Singhal A, et al: Molecular studies of liver disease in erythropoietic 162. Rand EB, Bunin N, Cochran W, et al: Sequential liver and bone marrow transplanta-
protoporphyria. J Clin Gastroenterol 39(4 Suppl 2):S167, 2005. tion for treatment of erythropoietic protoporphyria. Pediatrics 118(6):e1896, 2006.
127. Mathews-Roth MM: Systemic photoprotection. Dermatol Clin 4(2):335, 1986. 163. Richard E, Robert E, Cario-Andre M, et al: Hematopoietic stem cell gene therapy of
128. De Leo VA, Poh-Fitzpatrick M, Mathews-Roth M, et al: Erythropoietic protoporphy- murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo
ria. 10 years experience. Am J Med 60:8, 1976. drug selection. Gene Ther 11(22):1638, 2004.
129. Delaby C, Lyoumi S, Ducamp S, et al: Excessive erythrocyte ppix influences the hema- 164. Hassoun A, Verstraeten L, Mercelis R, et al: Biochemical diagnosis of an hereditary
tologic status and iron metabolism in patients with dominant erythropoietic protopor- aminolaevulinate dehydratase deficiency in a 63-year-old man. J Clin Chem Clin Bio-
phyria. Cell Mol Biol (Noisy-le-grand) 55(1):45, 2009. chem 27(10):781, 1989.
130. Turnbull A, Baker H, Vernon-Roberts B, et al: Iron metabolism in porphyria cutanea 165. Pawliuk R, Tighe R, Wise RJ, et al: Prevention of murine erythropoietic protoporphyr-
tarda and in erythropoietic protoporphyria. Q J Med 42:341, 1973. ia-associated skin photosensitivity and liver disease by dermal and hepatic ferrochela-
131. Holme SA, Worwood M, Anstey AV, et al: Erythropoiesis and iron metabolism in tase. J Invest Dermatol 124(1):256, 2005.
dominant erythropoietic protoporphyria. Blood 110(12):4108, 2007. 166. Plewinska M, Thunell S, Holmberg L, et al: Delta-aminolevulinate dehydratase defi-
132. Rademakers LH, Koningsberger JC, Sorber CW, et al: Accumulation of iron in ery- cient porphyria: Identification of the molecular lesions in a severely affected homozy-
throblasts of patients with erythropoietic protoporphyria. Eur J Clin Invest 23(2):130, gote. Am J Hum Genet 49(1):167, 1991.
1993. 167. Sassa S: ALAD porphyria. Semin Liver Dis 18(1):95, 1998.
133. Barman-Aksozen J, Beguin C, Dogar AM, et al: Iron availability modulates aberrant 168. Akagi R, Kato N, Inoue R, et al: delta-Aminolevulinate dehydratase (ALAD) porphy-
splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase ria: The first case in North America with two novel ALAD mutations. Mol Genet Metab
Jmjd6 and U2AF(65). Blood Cells Mol Dis 51(3):151, 2013. 87:329, 2006.
134. Barman-Aksozen J, Minder EI, Schubiger C, et al: In ferrochelatase-deficient pro- 169. Akagi R, Nishitani C, Harigae H, et al: Molecular analysis of delta-aminolevulinate
toporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin dehydratase deficiency in a patient with an unusual late-onset porphyria. Blood
concentration correlates with iron availability. Blood Cells Mol Dis 2014. 96(10):3618, 2000.
135. Poh-Fitzpatrick MB: Human protoporphyria: Reduced cutaneous photosensitivity and 170. Akagi R, Yasui Y, Harper P, et al: A novel mutation of delta-aminolaevulinate dehydra-
lower erythrocyte porphyrin levels during pregnancy. J Am Acad Dermatol 36(1):40, 1997. tase in a healthy child with 12% erythrocyte enzyme activity. Br J Haematol 106(4):931,
136. Rank JM, Carithers R, Bloomer J: Evidence for neurological dysfunction in end-stage 1999.
protoporphyric liver disease. Hepatology 18(6):1404, 1993. 171. Akagi R, Inoue R, Muranaka S, et al: Dual gene defects involving delta-aminolaevuli-
137. Doss MO, Frank M: Hepatobiliary implications and complications in protoporphyria, nate dehydratase and coproporphyrinogen oxidase in a porphyria patient. Br J Haema-
a 20-year study. Clin Biochem 22:223, 1989. tol 132:237, 2006 [erratum in: Br J Haematol 132(5):662, 2006].
138. Singer JA, Plaut AG, Kaplan MM: Hepatic failure and death from erythropoietic pro- 172. Thunell S, Henrichson A, Floderus Y, et al: Liver transplantation in a boy with acute
toporphyria. Gastroenterology 74(3):588, 1978. porphyria due to aminolaevulinate dehydratase deficiency. Eur J Clin Chem Clin Bio-
139. Key NS, Rank JM, Freese D, et al: Hemolytic anemia in protoporphyria: Possible pre- chem 30(10):599, 1992.
cipitating role of liver failure and photic stress. Am J Hematol 39:202, 1992. 173. Shimizu Y, Ida S, Naruto H, et al: Excretion of porphyrins in urine and bile after the
140. Hastka J, Lasserre JJ, Schwarzbeck A, et al: Zinc protoporphyrin in anemia of chronic administration of delta-aminolevulinic acid. J Lab Clin Med 92:795, 1978.
disorders. Blood 81:1200, 1993. 174. Doss M, von Tiepermann R, Schneider J, et al: New type of hepatic porphyria with
141. Anderson KE, Sassa S, Peterson CM, et al: Increased erythrocyte uroporphyrino- porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin
gen-I-synthetase, d-aminolevulinic acid dehydratase and protoporphyrin in hemolytic Wochenschr 57(20):1123, 1979.
anemias. Am J Med 63:359, 1977. 175. Gross U, Sassa S, Jacob K, et al: 5-Aminolevulinic acid dehydratase deficiency porphy-
142. Poh-Fitzpatrick MB, DeLeo VA: Rates of plasma porphyrin disappearance in fluores- ria: A twenty-year clinical and biochemical follow-up. Clin Chem 44(9):1892, 1998.
cent vs. red incandescent light exposure. J Invest Dermatol 69(6):510, 1977. 176. Doss MO, Stauch T, Gross U, et al: The third case of Doss porphyria (delta-amino-le-
143. Mathews-Roth MM, Pathak MA, Fitzpatrick TB, et al: Beta carotene therapy for vulinic acid dehydratase deficiency) in Germany. J Inherit Metab Dis 27(4):529, 2004.
erythropoietic protoporphyria and other photosensitivity diseases. Arch Dermatol 177. Thunell S, Holmberg L, Lundgren J: Aminolaevulinate dehydratase porphyria in
113(9):1229, 1977. infancy. A clinical and biochemical study. J Clin Chem Clin Biochem 25(1):5, 1987.
144. Minder EI, Schneider-Yin X, Steurer J, et al: A systematic review of treatment options 178. Mercelis R, Hassoun A, Verstraeten L, et al: Porphyric neuropathy and hereditary del-
for dermal photosensitivity in erythropoietic protoporphyria. Cell Mol Biol (Noisy-le- ta-aminolevulinic acid dehydratase deficiency in an adult. J Neurol Sci 95:39, 1990.
grand) 55(1):84, 2009. 179. Fujita H, Sato K, Sano S: Increase in the amount of erythrocyte delta-aminolevulinic
145. Mathews-Roth MM, Rosner B: Long-term treatment of erythropoietic protoporphyria acid dehydratase in workers with moderate lead exposure. Int Arch Occup Environ
with cysteine. Photodermatol Photoimmunol Photomed 18(6):307, 2002. Health 50(3):287, 1982.
146. Warren LJ, George S: Erythropoietic protoporphyria treated with narrow-band (TL- 180. Sassa S, Fujita H, Kappas A: Succinylacetone and delta-aminolevulinic acid dehydratase
01) UVB phototherapy. Australas J Dermatol 39(3):179, 1998. in hereditary tyrosinemia: Immunochemical study of the enzyme. Pediatrics 86(1):84,
147. Harms J, Lautenschlager S, Minder CE, et al: An alpha-melanocyte-stimulating hor- 1990.
mone analogue in erythropoietic protoporphyria. N Engl J Med 360(3):306, 2009. 181. Goldberg A, Moore MR, McColl KEL, et al: Porphyrin metabolism and the porphyrias,
148. Gordeuk VR, Brittenham GM, Hawkins CW, et al: Iron therapy for hepatic dysfunc- in Oxford Textbook of Medicine, edited by Ledingham DA, Warrell DA, Wetherall DJ, p
tion in erythropoietic protoporphyria. Ann Intern Med 105:27, 1986. 9136. Oxford University Press, Oxford, 1987.
149. Mercurio MG, Prince G, Weber FL, et al: Terminal hepatic failure in erythropoietic 182. Mustajoki P, Koskelo P: Hereditary hepatic porphyrias in Finland. Acta Med Scand
protoporphyria. J Am Acad Dermatol 29:829, 1993. 200(3):171, 1976.

Kaushansky_chapter 58_p0889-0914.indd 911 9/18/15 5:58 PM